Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318149 | 1.00 | HPGD (0.49) | HPGDMEN1KMT2ANR5A1RAB9A | |
| SCHEMBL31111418 | 1.00 | HPGD (0.49) | HPGDMEN1KMT2ANR5A1RAB9A | |
| SCHEMBL28212995 | 0.86 | NR5A1 (0.55) | MEN1KMT2ANR5A1RAB9ATP53 | |
| SCHEMBL28212996 | 0.86 | NR5A1 (0.55) | MEN1KMT2ANR5A1RAB9ATP53 | |
| SCHEMBL3297164 | 0.86 | NR5A1 (0.55) | MEN1KMT2ANR5A1RAB9ATP53 | |
| SCHEMBL3297166 | 0.86 | NR5A1 (0.55) | MEN1KMT2ANR5A1RAB9ATP53 | |
| SCHEMBL7561057 | 0.83 | NR5A1 (0.51) | HPGDMEN1KMT2ANR5A1RAB9A | |
| SCHEMBL7561060 | 0.83 | NR5A1 (0.51) | HPGDMEN1KMT2ANR5A1RAB9A | |
| SCHEMBL5075324 | 0.82 | HPGD (0.58) | HPGDMEN1KMT2ARAB9AMAPT | |
| SCHEMBL5072961 | 0.82 | HPGD (0.58) | HPGDMEN1KMT2ARAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293948-B2 | Reagent for organic synthesis and method of organic synthesis reaction with the reagent | JITSUBO CO., LTD. (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20120108788-A1 | REAGENT FOR ORGANIC SYNTHESIS AND METHOD OF ORGANIC SYNTHESIS REACTION WITH THE REAGENT | JITSUBO CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-8093435-B2 | Reagent for organic synthesis and method of organic synthesis reaction with the reagent | JITSUBO CO., LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090299103-A1 | Reagent for Organic Synthesis and Method of Organic Synthesis Reaction with the Reagent | NATIONAL UNIVERSITY CORPORATION, TOKYO UNIVERSITY (JP) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299103-A1 | Reagent for Organic Synthesis and Method of Organic Synthesis Reaction with the Reagent | COASY, OSTC, OGA | HPGD 2148/4885MEN1 2088/4885KMT2A 1686/4885 |
| US-20120108788-A1 | REAGENT FOR ORGANIC SYNTHESIS AND METHOD OF ORGANIC SYNTHESIS REACTION WITH THE REAGENT | COASY, OSTC, OGA | HPGD 2148/4885MEN1 2088/4885KMT2A 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.